Read on Twitter
If this is not a major supply chain disruption, what is? First, a change in policy from stock-piling second doses of vaccines to direct distribution without informing key players. (1/5) https://www.washingtonpost.com/health/2021/01/15/trump-vaccine-reserve-used-up/
Then, repercussions for others (Norway, EU, you name it): (2/5) https://www.ft.com/content/e8177df6-04ae-4d20-8e62-ca76589c7653
In the meantime, some EU countries outbidding one another, others teaming up to beg the EC for more: (3/5) https://stm.fi/-/suomi-vetoaa-yhteiskirjeessa-eu-n-komissioon-biontech-pfizerin-rokotetoimitusten-varmistamiseksi
What next? Even to maintain giving the second doses to already vaccinated people, countries losing out will need to reconsider their supply chain, and use what they have to ensure they do not compromise those who got a first jab (only) so far. (4/5)
In a bidding war, nobody wins. Global production capacity being limited, this is bullwhipping par excellence.
Instead, we would need price caps and co-ordination. (5/5)
#COVID19 #supplychain #bullwhip #vaccine
@HERoS_EU @HUMLOGInstitute
Instead, we would need price caps and co-ordination. (5/5)
#COVID19 #supplychain #bullwhip #vaccine
@HERoS_EU @HUMLOGInstitute